Russell Investments Group Ltd. raised its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 364.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 73,241 shares of the company's stock after buying an additional 57,475 shares during the period. Russell Investments Group Ltd. owned about 0.12% of Guardian Pharmacy Services worth $1,484,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of the business. Franklin Resources Inc. bought a new stake in Guardian Pharmacy Services during the third quarter valued at about $8,575,000. Barclays PLC acquired a new stake in shares of Guardian Pharmacy Services in the third quarter worth $311,000. Charles Schwab Investment Management Inc. acquired a new stake in Guardian Pharmacy Services during the 4th quarter worth about $544,000. Rhumbline Advisers purchased a new position in Guardian Pharmacy Services during the fourth quarter valued at approximately $149,000. Finally, New York State Common Retirement Fund increased its holdings in shares of Guardian Pharmacy Services by 17.9% during the 4th quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock valued at $5,643,000 after purchasing an additional 42,368 shares in the last quarter.
Analyst Upgrades and Downgrades
Separately, Truist Financial lifted their price target on Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, April 11th.
Read Our Latest Analysis on GRDN
Guardian Pharmacy Services Trading Up 2.6 %
Shares of GRDN opened at $24.13 on Friday. The stock has a 50 day moving average price of $20.64 and a 200 day moving average price of $20.82. Guardian Pharmacy Services, Inc. has a one year low of $14.16 and a one year high of $25.74.
Guardian Pharmacy Services Company Profile
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
